drug
as of 2026-07-01Inert Compound
at a glance
DIETARY_SUPPLEMENT
Pre-approval / investigational in the US
Developed by Sheppard Pratt Health System
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
DIETARY_SUPPLEMENT
Indications
Investigational (via trials)
Trials
2
Synbiotic Compound to Reduce Symptoms of Schizophrenia
NCT04226898Phase 2Recruiting
Probiotics to Prevent Relapse After Hospitalization for Mania
NCT01731171—Completed
KOLs & investigators
1
Faith B Dickerson, PhD, MPHKOL score 5
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here